Medical Devices UAE

UAE Anesthesia & Respiratory Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UAE Anesthesia & Respiratory Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Product Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UAE · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $158.6 Mn Placeholder estimate
Estimate 2025 $175.2 Mn 0.5% of the global market
Projected 2034 $430.4 Mn 145.6% Adds $255.1 Mn over 9 forecast years
CAGR 2025–2034 10.5% Faster than 57% of 173 Medical Devices markets here
Key players 5
  • UAE is 0.51% of the global market.
  • In Middle East, the largest is Saudi Arabia at $601.1 Mn.
  • Fastest growing: Saudi Arabia at 11% a year.
  • UAE ranks 2nd of 2 by size in Middle East.

Market size projection

UAE

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$255.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Anesthesia & Respiratory Devices Market market size by year, UAE
YearMarket sizeChange that yearSince 2025
2024 (estimate) $158.6 Mn — —
2025 (base) $175.2 Mn +$16.6 Mn —
2026 (forecast) $193.6 Mn +$18.4 Mn +10.5%
2027 (forecast) $213.9 Mn +$20.3 Mn +22.1%
2028 (forecast) $236.4 Mn +$22.5 Mn +34.9%
2029 (forecast) $261.2 Mn +$24.8 Mn +49.1%
2030 (forecast) $288.7 Mn +$27.4 Mn +64.7%
2031 (forecast) $319.0 Mn +$30.3 Mn +82%
2032 (forecast) $352.5 Mn +$33.5 Mn +101.2%
2033 (forecast) $389.5 Mn +$37.0 Mn +122.3%
2034 (forecast) $430.4 Mn +$40.9 Mn +145.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

UAE Anesthesia & Respiratory Devices Market Analysis at a glance
Market size, 2025$175.2 Mn placeholder estimate
Forecast, 2034$430.4 Mn placeholder estimate
Growth (CAGR), 2025–203410.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct type and end user (see all)
Key playersGE Healthcare, Medtronic, Teleflex Inc, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA (see all)
Regulator in the UAEEDESource: Emirates Drug Establishment. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UAE Anesthesia & Respiratory Devices Market Executive Summary

Anesthesia breathing systems function to deliver inhaled gases to patients. These most often include a mixture of fresh gas (oxygen, air) and anesthetic gases, both volatile agents (e.g., isoflurane) and non-volatile agents (nitrous oxide).

The Anesthesia and Respiratory Devices Market is experiencing significant growth, driven by the rising prevalence of respiratory diseases like COPD and sleep apnea, an aging population, and the increasing number of surgeries requiring anesthesia. Key segments include anesthesia machines, ventilators, and CPAP devices, with major players like Medtronic and GE Healthcare leading the market. North America dominates, while the Asia-Pacific region is expected to grow rapidly. Challenges include high device costs and stringent regulations, but advancements in portable and AI-integrated devices are expected to fuel future growth.

Bar chart: UAE Anesthesia & Respiratory Devices market size, 2024–2034, placeholder estimates. $158.6 Mn in 2024, $175.2 Mn in 2025 and $430.4 Mn in 2034, 10.5% CAGR.
UAE Anesthesia & Respiratory Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UAE Anesthesia & Respiratory Devices Market Dynamics

Market Growth Drivers

Chronic respiratory diseases, including COPD, asthma, and sleep apnea affect about 545 Mn people, which indicate an increasing need for respiratory care devices and solutions. Furthermore, there has been a global increase in the number of surgeries—approximately 230 Mn major surgeries annually—further stimulating the development of enhanced anesthesia devices. The development of new technologies and integration of intelligence and smart features not only increases the effectiveness of these devices but also increases their applications in clinical settings.

Opportunity

The availability of opportunities in Asia-Pacific, Latin America, and the Middle East & Africa due to better healthcare and gradually growing incomes are expected to be lucrative for anesthesia and respiratory devices. Other drivers include aging population that increases the need for specialized medical devices while the population of children is also on the rise, making the need for pediatric devices higher.

Market Restraints

Expensive equipment, maintenance costs, and the financial burden of training personnel are key barriers to adoption, especially in developing regions. Severe market competition results in increased pressure to reduce prices, which affects the revenue and investment in research. Fluctuations in the economic cycle and available funds limit investment in new technologies, while lack of awareness in some new markets may hinder the use of superior devices.

Competitive Landscape for Anesthesia & Respiratory Devices Market in UAE

Key Players

Recent Developments

April 2024, Johnson & Johnson launched two new devices in EMEA. The Ethizia haemostatic sealing patch and the Cereglide aspiration catheter were launched last week by two J&J medtech companies.

August 2025, Mindray Introduced Innovative Upgrades to A Series Anesthesia Systems for Enhanced Patient Safety and Efficiency. Mindray has unveiled exciting upgrades to its A7 and A5 anesthesia systems under the A Series Anesthesia. The brand-new enhancements incorporate innovative technologies that empower anesthesiologists to deliver precise anesthesia, leading to greater patient safety and efficiency throughout the perioperative period.

April 2022, GE Healthcare Received FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery.

Mergers and Acquisitions

October 2025, AirLife, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care formerly known as SunMed, announced the completion of its acquisition of Avanos Medical, Inc.’s respiratory health business, including the BALLARD, MICROCUFF and endOclear product lines.

Healthcare Policies and Regulatory Landscape for Anesthesia & Respiratory Devices Market in UAE

Anesthesia & Respiratory Devices in the UAE: rules and payment

The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention.⁠[1] Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate.⁠[2]

[1] Emirates Drug Establishment. Checked 14 Nov 2026.

[2] Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

There is high stringency in the regulatory environment of anesthesia and respiratory related devices which can include high approval hurdles and frequently changing standards that can slow down the market entry and entail steep expenses. They have favourable reimbursement policies which help in boosting up the market in the developed country while in the emerging country matters may be slightly difficult due to the absence of well-formulated reimbursement policies. Further, reimbursement pressures are compounded with possible future reductions in coverage and reduced reimbursement for devices and services, newly introduced principles of value-based purchasing and need for better reporting of cost-effectiveness and positive patient outcomes in order to gain reimbursement and adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Anesthesia & Respiratory Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Anesthesia & Respiratory Devices in context

The UAE compared

  • Health spending per person: 2,402 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 2.99 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 3rd highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 1.8% of people (2025). World: 10.4% of people (2025). 8th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Anesthesia & Respiratory Devices market in the UAE?
Placeholder estimate: about $175.2 Mn in 2025, rising to about $430.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Anesthesia & Respiratory Devices market in the UAE growing?
Placeholder estimate: about 10.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Anesthesia & Respiratory Devices market report cover?
The report splits the market by product type (Anesthesia Devices, Respiratory Devices) and end user (Hospitals, Clinics, Homecare Settings, Ambulatory Service Centres).
Who are the key players in the Anesthesia & Respiratory Devices market?
Key players include GE Healthcare, Medtronic, Teleflex Inc, Koninklijke Philips N.V. and Drägerwerk AG & Co. KGaA.
What is driving the Anesthesia & Respiratory Devices market?
Chronic respiratory diseases, including COPD, asthma, and sleep apnea affect about 545 Mn people, which indicate an increasing need for respiratory care devices and solutions.
Who regulates Anesthesia & Respiratory Devices in the UAE?
The Emirates Drug Establishment (EDE), set up in 2023, is taking over the regulation of medical devices from the Ministry of Health and Prevention. Source: Emirates Drug Establishment. Checked 14 Nov 2026.
How is healthcare paid for in the UAE?
Since January 2025, basic health insurance has been mandatory for all private-sector employees and domestic workers in every emirate. Source: Ministry of Human Resources and Emiratisation. Checked 14 Nov 2026.
How much research is published on Anesthesia & Respiratory Devices?
PubMed lists 7,161 papers on Anesthesia & Respiratory Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in UAE

See all

Related on respiratory and surgery

See the topic